AxoGen Stock Price, News & Analysis (NASDAQ:AXGN)

$26.20 -0.25 (-0.95 %)
(As of 12/13/2017 07:49 AM ET)
Previous Close$26.45
Today's Range$26.05 - $26.95
52-Week Range$8.25 - $27.60
Volume219,100 shs
Average Volume216,985 shs
Market Capitalization$901.78 million
P/E RatioN/A
Dividend YieldN/A
Beta0.41

About AxoGen (NASDAQ:AXGN)

AxoGen logoAxoGen, Inc. provides surgical solutions for peripheral nerve injuries. The company’s surgical nerve repair solutions include Avance Nerve Graft, an off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect injured peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its solutions also comprise Avive Soft Tissue Membrane, a minimally processed human umbilical cord membrane that is used as a resorbable soft tissue covering to separate tissues and modulate inflammation in the surgical bed. In addition, the company offers AcroVal neurosensory and motor testing system, which consists of AcroGrip for use in hand grip strength measurement; AcroPinch for measuring pinch strength; and Pressure-Specified Sensory Device, a somatosensory evaluation and measurement device. Further, it provides AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals in the United States, Canada, the United Kingdom and other European countries, and internationally. AxoGen, Inc. is headquartered in Alachua, Florida.

Receive AXGN News and Ratings via Email

Sign-up to receive the latest news and ratings for AXGN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Appliances & Equipment
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:AXGN
CUSIPN/A
Phone386-462-6800

Debt

Debt-to-Equity Ratio1.93%
Current Ratio3.55%
Quick Ratio2.95%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$41.11 million
Price / Sales21.73
Cash FlowN/A
Price / CashN/A
Book Value$0.45 per share
Price / Book58.22

Profitability

Trailing EPS($0.40)
Net Income$-14,410,000.00
Net Margins-24.74%
Return on Equity-91.00%
Return on Assets-25.48%

Miscellaneous

Employees146
Outstanding Shares34,090,000

AxoGen (NASDAQ:AXGN) Frequently Asked Questions

What is AxoGen's stock symbol?

AxoGen trades on the NASDAQ under the ticker symbol "AXGN."

How were AxoGen's earnings last quarter?

AxoGen, Inc. (NASDAQ:AXGN) posted its quarterly earnings data on Wednesday, November, 1st. The medical equipment provider reported ($0.06) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.06). The medical equipment provider earned $16.05 million during the quarter, compared to the consensus estimate of $15.55 million. AxoGen had a negative net margin of 24.74% and a negative return on equity of 91.00%. The business's revenue for the quarter was up 43.2% compared to the same quarter last year. View AxoGen's Earnings History.

Where is AxoGen's stock going? Where will AxoGen's stock price be in 2017?

6 Wall Street analysts have issued twelve-month price targets for AxoGen's shares. Their predictions range from $18.00 to $35.00. On average, they expect AxoGen's share price to reach $26.17 in the next twelve months. View Analyst Ratings for AxoGen.

Who are some of AxoGen's key competitors?

Who owns AxoGen stock?

AxoGen's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Bank of New York Mellon Corp (1.89%), Russell Investments Group Ltd. (1.74%), Gilder Gagnon Howe & Co. LLC (1.69%), Perkins Capital Management Inc. (1.62%), Cortina Asset Management LLC (1.46%) and EAM Investors LLC (0.87%). Company insiders that own AxoGen stock include Amy Mcbride Wendell, Guido J Neels, James E Flynn, Jamie Mark Grooms, John P Engels, Joseph M Mandato, Karen L Zaderej, Peter J Mariani and Robert James Rudelius. View Institutional Ownership Trends for AxoGen.

Who sold AxoGen stock? Who is selling AxoGen stock?

AxoGen's stock was sold by a variety of institutional investors in the last quarter, including Lyon Street Capital LLC, Columbia Partners L L C Investment Management, Citadel Advisors LLC, Russell Investments Group Ltd., Granite Point Capital Management L.P., Perkins Capital Management Inc., Ameriprise Financial Inc. and Wells Fargo & Company MN. Company insiders that have sold AxoGen company stock in the last year include Guido J Neels, Jamie Mark Grooms and Robert James Rudelius. View Insider Buying and Selling for AxoGen.

Who bought AxoGen stock? Who is buying AxoGen stock?

AxoGen's stock was purchased by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Bamco Inc. NY, Schwab Charles Investment Management Inc., Pura Vida Investments LLC, Advisors Asset Management Inc., Strs Ohio, Catalyst Capital Advisors LLC and Campbell & CO Investment Adviser LLC. Company insiders that have bought AxoGen stock in the last two years include Amy Mcbride Wendell, John P Engels, Karen L Zaderej and Peter J Mariani. View Insider Buying and Selling for AxoGen.

How do I buy AxoGen stock?

Shares of AxoGen can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is AxoGen's stock price today?

One share of AxoGen stock can currently be purchased for approximately $26.20.

How big of a company is AxoGen?

AxoGen has a market capitalization of $901.78 million and generates $41.11 million in revenue each year. The medical equipment provider earns $-14,410,000.00 in net income (profit) each year or ($0.40) on an earnings per share basis. AxoGen employs 146 workers across the globe.

How can I contact AxoGen?

AxoGen's mailing address is 13631 PROGRESS BLVD. SUITE 400, ALACHUA FL, 32615. The medical equipment provider can be reached via phone at 386-462-6800 or via email at [email protected]


MarketBeat Community Rating for AxoGen (AXGN)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  124 (Vote Outperform)
Underperform Votes:  62 (Vote Underperform)
Total Votes:  186
MarketBeat's community ratings are surveys of what our community members think about AxoGen and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

AxoGen (NASDAQ:AXGN) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $26.17$18.00$17.20$13.17
Price Target Upside: 1.82% upside12.41% downside5.75% downside5.28% downside

AxoGen (NASDAQ:AXGN) Consensus Price Target History

Price Target History for AxoGen (NASDAQ:AXGN)

AxoGen (NASDAQ:AXGN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/30/2017Jefferies GroupInitiated CoverageBuy -> Buy$35.00HighView Rating Details
11/21/2017Leerink SwannBoost Price TargetOutperform -> Outperform$26.00 -> $30.00N/AView Rating Details
11/21/2017Lake Street CapitalBoost Price TargetBuy -> Buy$22.00 -> $26.00N/AView Rating Details
11/21/2017WedbushReiterated RatingBuy$22.00 -> $27.00N/AView Rating Details
9/12/2017Roth CapitalReiterated RatingBuy$18.00 -> $21.00LowView Rating Details
8/21/2017Cantor FitzgeraldReiterated RatingBuy$18.00LowView Rating Details
11/22/2016JMP SecuritiesReiterated RatingBuyN/AView Rating Details
(Data available from 12/13/2015 forward)

Earnings

AxoGen (NASDAQ:AXGN) Earnings History and Estimates Chart

Earnings by Quarter for AxoGen (NASDAQ:AXGN)

AxoGen (NASDAQ AXGN) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/1/2017Q3 2017($0.06)($0.06)$15.55 million$16.05 millionViewN/AView Earnings Details
8/2/2017Q2 2017($0.08)($0.06)$14.40 million$15.20 millionViewListenView Earnings Details
5/4/2017Q1 2017($0.10)($0.11)$11.83 million$12.24 millionViewListenView Earnings Details
2/22/2017Q4 2016($0.09)($0.10)$11.41 millionViewListenView Earnings Details
11/2/2016Q3 2016($0.08)($0.08)$11.21 million$11.21 millionViewN/AView Earnings Details
8/3/2016Q2($0.12)($0.09)$9.28 million$10.38 millionViewN/AView Earnings Details
11/5/2015Q3 2015($0.12)($0.11)$6.70 million$8.15 millionViewN/AView Earnings Details
8/6/2015Q2 2015($0.15)($0.13)$5.89 million$6.42 millionViewN/AView Earnings Details
5/5/2015Q1 2015($0.17)($0.16)$4.90 million$4.95 millionViewN/AView Earnings Details
11/13/2014Q3 2014($0.24)($0.19)$4.67 millionViewN/AView Earnings Details
8/4/2014Q2 2014($0.22)($0.21)$3.30 million$4.21 millionViewN/AView Earnings Details
4/30/2014Q1 2014($0.26)($0.24)$2.75 million$3.14 millionViewN/AView Earnings Details
3/6/2014($0.22)($0.24)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

AxoGen (NASDAQ:AXGN) Earnings Estimates

2017 EPS Consensus Estimate: ($0.29)
2018 EPS Consensus Estimate: ($0.19)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173($0.12)($0.07)($0.10)
Q2 20173($0.06)($0.04)($0.05)
Q3 20174($0.10)($0.03)($0.06)
Q4 20174($0.11)($0.04)($0.07)
Q1 20183($0.10)$0.01($0.05)
Q2 20183($0.07)$0.03($0.02)
Q3 20183($0.08)$0.04($0.04)
Q4 20182($0.09)($0.05)($0.07)
Q1 20191($0.04)($0.04)($0.04)
Q2 20191($0.04)($0.04)($0.04)
Q3 20191($0.04)($0.04)($0.04)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for AxoGen (NASDAQ:AXGN)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

AxoGen (NASDAQ AXGN) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 9.33%
Institutional Ownership Percentage: 66.00%
Insider Trades by Quarter for AxoGen (NASDAQ:AXGN)
Insider Trades by Quarter for AxoGen (NASDAQ:AXGN)

AxoGen (NASDAQ AXGN) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/8/2017Jamie Mark GroomsDirectorSell84,295$26.38$2,223,702.10View SEC Filing  
12/6/2017Jamie Mark GroomsDirectorSell21,290$26.22$558,223.80View SEC Filing  
11/20/2017Guido J NeelsDirectorSell1,150,000$19.74$22,701,000.00View SEC Filing  
9/11/2017Robert James RudeliusDirectorSell16,143$18.00$290,574.00View SEC Filing  
10/7/2016Amy Mcbride WendellDirectorBuy13,333$7.50$99,997.50View SEC Filing  
10/7/2016John P EngelsVPBuy4,000$7.50$30,000.00View SEC Filing  
10/7/2016Karen L ZaderejCEOBuy10,000$7.50$75,000.00View SEC Filing  
10/7/2016Peter J MarianiCFOBuy3,333$7.50$24,997.50View SEC Filing  
8/9/2016Joseph M MandatoDirectorSell149,618$8.54$1,277,737.72View SEC Filing  
8/8/2016Joseph M MandatoDirectorSell107,450$8.63$927,293.50View SEC Filing  
7/21/2016James E FlynnInsiderSell102,136$6.70$684,311.20View SEC Filing  
7/18/2016James E FlynnInsiderSell279,303$7.53$2,103,151.59View SEC Filing  
9/18/2015James E FlynnInsiderSell345,000$5.50$1,897,500.00View SEC Filing  
6/3/2015Joseph M MandatoDirectorBuy6,500$3.10$20,150.00View SEC Filing  
6/2/2015Lee Robert Johnston JrInsiderBuy5,000$3.06$15,300.00View SEC Filing  
4/8/2015James E FlynnInsiderSell144,385$3.25$469,251.25View SEC Filing  
12/10/2014Lee Robert Johnston JrCFOBuy10,000$3.06$30,600.00View SEC Filing  
8/12/2014Mark Stephen GoldDirectorBuy20,000$2.29$45,800.00View SEC Filing  
8/8/2014Mark Stephen GoldDirectorBuy11,000$2.31$25,410.00View SEC Filing  
6/6/2014Lee Robert Johnston JrCFOBuy10,000$2.58$25,800.00View SEC Filing  
6/3/2014Gregory Gene FreitagCFOBuy5,200$2.45$12,740.00View SEC Filing  
6/3/2014Karen L ZaderejCEOBuy5,000$2.43$12,150.00View SEC Filing  
5/20/2014Jill F SchiaparelliSVPBuy2,000$2.63$5,260.00View SEC Filing  
5/12/2014Karen L ZaderejCEOBuy5,000$2.70$13,500.00View SEC Filing  
5/7/2014Mark Stephen GoldDirectorBuy1,977$2.60$5,140.20View SEC Filing  
3/13/2014Karen L ZaderejCEOBuy1,500$3.49$5,235.00View SEC Filing  
8/29/2013Shawn F MccarreySVPBuy25,000$3.21$80,250.00View SEC Filing  
8/24/2013Shawn F MccarreySVPBuy5,000$3.00$15,000.00View SEC Filing  
8/14/2013Jill F SchiaparelliSVPBuy5,000$3.00$15,000.00View SEC Filing  
8/14/2013John Frederick HarperDirectorBuy66,666$3.00$199,998.00View SEC Filing  
8/14/2013Karen L ZaderejCEOBuy8,334$3.00$25,002.00View SEC Filing  
12/4/2012Jill F SchiaparelliSVPBuy2,000$2.55$5,100.00View SEC Filing  
11/29/2012Jill F SchiaparelliSVPBuy1,000$2.70$2,700.00View SEC Filing  
11/15/2012Jill F SchiaparelliSVPBuy2,750$2.56$7,040.00View SEC Filing  
10/1/2012John Frederick HarperDirectorBuy86,557$3.61$312,470.77View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

AxoGen (NASDAQ AXGN) News Headlines

Source:
DateHeadline
AxoGen (AXGN) vs. Integer (ITGR) Head-To-Head ReviewAxoGen (AXGN) vs. Integer (ITGR) Head-To-Head Review
www.americanbankingnews.com - December 12 at 1:40 PM
AxoGen (AXGN) versus Integer (ITGR) Critical ReviewAxoGen (AXGN) versus Integer (ITGR) Critical Review
www.americanbankingnews.com - December 10 at 12:14 PM
Reviewing AxoGen (AXGN) and Arch Therapeutics (ARTH)Reviewing AxoGen (AXGN) and Arch Therapeutics (ARTH)
www.americanbankingnews.com - December 10 at 3:50 AM
Analyzing Integer (ITGR) and AxoGen (AXGN)Analyzing Integer (ITGR) and AxoGen (AXGN)
www.americanbankingnews.com - December 9 at 8:26 AM
Insider Selling: AxoGen, Inc. (AXGN) Director Sells 21,290 Shares of StockInsider Selling: AxoGen, Inc. (AXGN) Director Sells 21,290 Shares of Stock
www.americanbankingnews.com - December 8 at 11:16 PM
AxoGen, Inc. (AXGN) Director Jamie Mark Grooms Sells 84,295 SharesAxoGen, Inc. (AXGN) Director Jamie Mark Grooms Sells 84,295 Shares
www.americanbankingnews.com - December 8 at 8:28 PM
Critical Review: AxoGen (AXGN) and Arch Therapeutics (ARTH)Critical Review: AxoGen (AXGN) and Arch Therapeutics (ARTH)
www.americanbankingnews.com - December 7 at 7:28 PM
AxoGen, Inc. (AXGN) to Post FY2017 Earnings of ($0.33) Per Share, Jefferies Group ForecastsAxoGen, Inc. (AXGN) to Post FY2017 Earnings of ($0.33) Per Share, Jefferies Group Forecasts
www.americanbankingnews.com - December 4 at 2:22 AM
$16.06 Million in Sales Expected for AxoGen, Inc. (AXGN) This Quarter$16.06 Million in Sales Expected for AxoGen, Inc. (AXGN) This Quarter
www.americanbankingnews.com - December 3 at 12:28 PM
ETFs with exposure to AxoGen, Inc. : December 1, 2017ETFs with exposure to AxoGen, Inc. : December 1, 2017
finance.yahoo.com - December 1 at 6:27 PM
AxoGen (AXGN) Receives New Coverage from Analysts at Jefferies GroupAxoGen (AXGN) Receives New Coverage from Analysts at Jefferies Group
www.americanbankingnews.com - November 30 at 6:10 PM
AxoGen, Inc. (AXGN) Given Average Rating of "Buy" by AnalystsAxoGen, Inc. (AXGN) Given Average Rating of "Buy" by Analysts
www.americanbankingnews.com - November 27 at 7:46 AM
Contrasting Integer (ITGR) and AxoGen (AXGN)Contrasting Integer (ITGR) and AxoGen (AXGN)
www.americanbankingnews.com - November 26 at 9:20 PM
Q2 2018 EPS Estimates for AxoGen, Inc. Decreased by Leerink Swann (AXGN)Q2 2018 EPS Estimates for AxoGen, Inc. Decreased by Leerink Swann (AXGN)
www.americanbankingnews.com - November 23 at 1:26 PM
Financial Analysis: Integer Holdings Corporation (ITGR) versus AxoGen (AXGN)Financial Analysis: Integer Holdings Corporation (ITGR) versus AxoGen (AXGN)
www.americanbankingnews.com - November 22 at 1:23 PM
AxoGen, Inc. (Nasdaq: AXGN) to Ring The Nasdaq Stock Market Opening Bell - GlobeNewswire (press release)AxoGen, Inc. (Nasdaq: AXGN) to Ring The Nasdaq Stock Market Opening Bell - GlobeNewswire (press release)
globenewswire.com - November 22 at 2:51 AM
AxoGen, Inc. (AXGN) PT Raised to $27 at Wedbush Following ... - StreetInsider.comAxoGen, Inc. (AXGN) PT Raised to $27 at Wedbush Following ... - StreetInsider.com
www.streetinsider.com - November 21 at 9:50 PM
AxoGen, Inc. (AXGN) PT Raised to $27 at JMP Securities Following Analyst Day - StreetInsider.comAxoGen, Inc. (AXGN) PT Raised to $27 at JMP Securities Following Analyst Day - StreetInsider.com
www.streetinsider.com - November 21 at 9:50 PM
AxoGen, Inc. (AXGN) Price Target Raised to $30.00 at Leerink SwannAxoGen, Inc. (AXGN) Price Target Raised to $30.00 at Leerink Swann
www.americanbankingnews.com - November 21 at 5:40 PM
AxoGen, Inc. (AXGN) PT Raised to $26 at Lake Street Capital MarketsAxoGen, Inc. (AXGN) PT Raised to $26 at Lake Street Capital Markets
www.streetinsider.com - November 21 at 4:49 PM
AxoGen, Inc. (AXGN) Director Sells $22,701,000.00 in StockAxoGen, Inc. (AXGN) Director Sells $22,701,000.00 in Stock
www.americanbankingnews.com - November 21 at 4:18 PM
AxoGen, Inc. (AXGN) Price Target Raised to $26.00AxoGen, Inc. (AXGN) Price Target Raised to $26.00
www.americanbankingnews.com - November 21 at 9:38 AM
Wedbush Reaffirms "Outperform" Rating for AxoGen, Inc. (AXGN)Wedbush Reaffirms "Outperform" Rating for AxoGen, Inc. (AXGN)
www.americanbankingnews.com - November 21 at 7:43 AM
AxoGen Advances its Platform for Nerve Repair at Annual Analyst and Investor DayAxoGen Advances its Platform for Nerve Repair at Annual Analyst and Investor Day
finance.yahoo.com - November 20 at 5:34 PM
AxoGen, Inc. (Nasdaq: AXGN) to Ring The Nasdaq Stock Market Opening BellAxoGen, Inc. (Nasdaq: AXGN) to Ring The Nasdaq Stock Market Opening Bell
finance.yahoo.com - November 20 at 5:34 PM
AxoGen Announces Closing of Public Offering of Common StockAxoGen Announces Closing of Public Offering of Common Stock
finance.yahoo.com - November 20 at 5:34 PM
Integer Holdings Corporation (ITGR) vs. AxoGen (AXGN) Head-To-Head ContrastInteger Holdings Corporation (ITGR) vs. AxoGen (AXGN) Head-To-Head Contrast
www.americanbankingnews.com - November 19 at 11:36 AM
AxoGen, Inc. Announces Proposed Public Offering of Common Stock - GlobeNewswire (press release)AxoGen, Inc. Announces Proposed Public Offering of Common Stock - GlobeNewswire (press release)
globenewswire.com - November 17 at 9:54 AM
AxoGen, Inc. Announces Pricing of Public Offering of Common Stock - GlobeNewswire (press release)AxoGen, Inc. Announces Pricing of Public Offering of Common Stock - GlobeNewswire (press release)
globenewswire.com - November 17 at 9:54 AM
AxoGen (AXGN) Prices Public Offering of Common Stock at $21/ShareAxoGen (AXGN) Prices Public Offering of Common Stock at $21/Share
www.streetinsider.com - November 16 at 4:35 PM
AxoGen (AXGN) Announces 1M Share Common OfferingAxoGen (AXGN) Announces 1M Share Common Offering
www.streetinsider.com - November 16 at 11:44 AM
AxoGen, Inc. Announces Proposed Public Offering of Common StockAxoGen, Inc. Announces Proposed Public Offering of Common Stock
finance.yahoo.com - November 16 at 11:44 AM
AxoGen, Inc. Announces Pricing of Public Offering of Common StockAxoGen, Inc. Announces Pricing of Public Offering of Common Stock
finance.yahoo.com - November 16 at 11:44 AM
ETFs with exposure to AxoGen, Inc. : November 16, 2017ETFs with exposure to AxoGen, Inc. : November 16, 2017
finance.yahoo.com - November 16 at 11:44 AM
Critical Survey: AxoGen (AXGN) vs. Integer Holdings Corporation (ITGR)Critical Survey: AxoGen (AXGN) vs. Integer Holdings Corporation (ITGR)
www.americanbankingnews.com - November 15 at 3:48 AM
AxoGen, Inc. to Present at the 29th Annual Piper Jaffray Healthcare ConferenceAxoGen, Inc. to Present at the 29th Annual Piper Jaffray Healthcare Conference
globenewswire.com - November 14 at 4:46 PM
AxoGen, Inc. to Present at the 29th Annual Piper Jaffray Healthcare ConferenceAxoGen, Inc. to Present at the 29th Annual Piper Jaffray Healthcare Conference
finance.yahoo.com - November 14 at 4:46 PM
AxoGen, Inc. (AXGN) Expected to Post Quarterly Sales of $16.06 MillionAxoGen, Inc. (AXGN) Expected to Post Quarterly Sales of $16.06 Million
www.americanbankingnews.com - November 14 at 9:58 AM
AxoGen, Inc. (AXGN) Expected to Announce Earnings of -$0.09 Per ShareAxoGen, Inc. (AXGN) Expected to Announce Earnings of -$0.09 Per Share
www.americanbankingnews.com - November 12 at 1:50 PM
AxoGen to Host Second Annual Analyst and Investor Day on November 20, 2017AxoGen to Host Second Annual Analyst and Investor Day on November 20, 2017
finance.yahoo.com - November 7 at 6:16 PM
ETFs with exposure to AxoGen, Inc. : November 6, 2017ETFs with exposure to AxoGen, Inc. : November 6, 2017
finance.yahoo.com - November 6 at 5:17 PM
Q4 2018 Earnings Estimate for AxoGen, Inc. Issued By Leerink Swann (AXGN)Q4 2018 Earnings Estimate for AxoGen, Inc. Issued By Leerink Swann (AXGN)
www.americanbankingnews.com - November 6 at 1:59 PM
Wedbush Weighs in on AxoGen, Inc.s FY2017 Earnings (AXGN)Wedbush Weighs in on AxoGen, Inc.'s FY2017 Earnings (AXGN)
www.americanbankingnews.com - November 6 at 8:00 AM
AxoGen, Inc. :AXGN-US: Earnings Analysis: Q3, 2017 By the Numbers : November 3, 2017AxoGen, Inc. :AXGN-US: Earnings Analysis: Q3, 2017 By the Numbers : November 3, 2017
finance.yahoo.com - November 3 at 4:44 PM
AxoGens (AXGN) CEO Karen Zaderej on Q3 2017 Results - Earnings Call TranscriptAxoGen's (AXGN) CEO Karen Zaderej on Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - November 2 at 4:52 PM
Edited Transcript of AXGN earnings conference call or presentation 1-Nov-17 8:30pm GMTEdited Transcript of AXGN earnings conference call or presentation 1-Nov-17 8:30pm GMT
finance.yahoo.com - November 2 at 4:52 PM
AxoGen, Inc. (AXGN) Given Consensus Recommendation of "Buy" by BrokeragesAxoGen, Inc. (AXGN) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - November 2 at 7:46 AM
AxoGen reports 3Q lossAxoGen reports 3Q loss
finance.yahoo.com - November 1 at 9:51 PM
AxoGen, Inc. (AXGN) Releases  Earnings Results, Meets ExpectationsAxoGen, Inc. (AXGN) Releases Earnings Results, Meets Expectations
www.americanbankingnews.com - November 1 at 5:47 PM
Notable Wednesday Option Activity: LFUS, AXGN, SYRS - NasdaqNotable Wednesday Option Activity: LFUS, AXGN, SYRS - Nasdaq
www.nasdaq.com - November 1 at 4:51 PM

SEC Filings

AxoGen (NASDAQ:AXGN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

AxoGen (NASDAQ:AXGN) Income Statement, Balance Sheet and Cash Flow Statement

Chart

AxoGen (NASDAQ AXGN) Stock Chart for Wednesday, December, 13, 2017

Loading chart…

This page was last updated on 12/13/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.